Evaluation of topical use of tranexamic acid in reducing hidden blood loss during surgical treatment of intertrochanteric fracture in the elderly

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800014309

Enrollment

Unknown

Registered

2018-01-05

Start date

2018-01-10

Completion date

Unknown

Last updated

2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intertrochanteric fracture

Interventions

tranexamic acid group:Tranexamic acid 1g is injected into the proximal femoral medullary cavity

control group:20 mL of saline is injected into the proximal femoral medullary cavity

Eligibility

Sex/Gender

All

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. aged =60 years; 2. intertrochanteric fracture treated with proximal femoral nail anti-rotation.

Exclusion criteria

Exclusion criteria: 1) has deep venous thrombosis before operation; 2) preoperative hemoglobin (Hb) 3 weeks.

Design outcomes

Primary

Measure	Time frame
hidden blood loss;	—

Secondary

Measure	Time frame
total perioperative blood loss;postoperative transfusion rate;	—

Countries

China

Contacts

Public ContactXiangping Luo

The People's Hospital of Leiyang

luoxiangping8@sina.com+86 18163885070

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026